Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN2B Antikörper

CDKN2B Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 3E4 unconjugated
Produktnummer ABIN2718414
  • Target Alle CDKN2B Antikörper anzeigen
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Reaktivität
    • 65
    • 16
    • 15
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 57
    • 8
    • 1
    Maus
    Klonalität
    • 59
    • 7
    Monoklonal
    Konjugat
    • 30
    • 7
    • 7
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CDKN2B Antikörper ist unkonjugiert
    Applikation
    • 54
    • 43
    • 36
    • 35
    • 25
    • 14
    • 6
    • 3
    • 1
    Western Blotting (WB), Flow Cytometry (FACS)
    Produktmerkmale
    Homo sapiens cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1
    Aufreinigung
    Purified from mouse ascites fluids by affinity chromatography
    Immunogen
    Full length human recombinant protein of human CDKN2B(NP_004927) produced in HEK293T cell.
    Klon
    3E4
    Isotyp
    IgG1
    Top Product
    Discover our top product CDKN2B Primärantikörper
  • Applikationshinweise
    WB 1:2000, FLOW 1:100,
    Kommentare

    The concentration of the product may vary between diferrent lots.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5-1.0 mg/mL
    Buffer
    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Target
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Andere Bezeichnung
    CDKN2B (CDKN2B Produkte)
    Synonyme
    p14-INK4b antikoerper, cdk4l antikoerper, ink4b antikoerper, mts2 antikoerper, p15 antikoerper, p15ink4b antikoerper, tp15 antikoerper, CDK4I antikoerper, INK4B antikoerper, MTS2 antikoerper, P15 antikoerper, TP15 antikoerper, p15INK4b antikoerper, AV083695 antikoerper, INK4b antikoerper, p15(INK4b) antikoerper, CDKN2A antikoerper, cyclin dependent kinase inhibitor 2B antikoerper, Cyclin-dependent kinase 4 inhibitor B antikoerper, cyclin-dependent kinase inhibitor 2B antikoerper, cyclin-dependent kinase inhibitor 2B L homeolog antikoerper, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) antikoerper, CDKN2B antikoerper, cdn2b antikoerper, cdkn2b antikoerper, cdkn2b.L antikoerper, Cdkn2b antikoerper
    Hintergrund
    This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported.
    Molekulargewicht
    14.5 kDa
    Gen-ID
    1030
    NCBI Accession
    NM_004936
    HGNC
    1030
    Pathways
    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Kundenservice